Ryota Nishimori
President presso CAC HOLDINGS CORPORATION
Patrimonio netto: 623 212 $ in data 31/03/2024
Profilo
Ryota Nishimori is currently the President & Representative Director at CAC Holdings Corp.
since 2021 and the President & Representative Director at CAC Corp.
(Japanese) since 2014.
He previously served as the President & Director at CAC America Corp.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
CAC HOLDINGS CORPORATION
0.23% | 31/12/2022 | 48 000 ( 0.23% ) | 623 212 $ | 31/03/2024 |
Posizioni attive di Ryota Nishimori
Società | Posizione | Inizio |
---|---|---|
CAC HOLDINGS CORPORATION | President | 01/01/2021 |
CAC KK
CAC KK Information Technology ServicesTechnology Services Part of CAC Holdings Corp., CAC Corp. (TY) is a Japanese company that supports all operations related to donations, significantly reducing time and effort while ensuring high transparency and safety. The private company is based in Tokyo, Japan. With standard functions, it can handle various types of applications, such as scholarships, general donations, academic society donations, research and development expenses, and donation applications from patient groups. Astellas Pharma, Novo Pharma, and several other pharmaceutical and medical device manufacturers have introduced this company. Founded in 2014. | President | 01/04/2014 |
Precedenti posizioni note di Ryota Nishimori
Società | Posizione | Fine |
---|---|---|
CAC America Corp. | President | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
CAC HOLDINGS CORPORATION | Technology Services |
Aziende private | 2 |
---|---|
CAC America Corp. | |
CAC KK
CAC KK Information Technology ServicesTechnology Services Part of CAC Holdings Corp., CAC Corp. (TY) is a Japanese company that supports all operations related to donations, significantly reducing time and effort while ensuring high transparency and safety. The private company is based in Tokyo, Japan. With standard functions, it can handle various types of applications, such as scholarships, general donations, academic society donations, research and development expenses, and donation applications from patient groups. Astellas Pharma, Novo Pharma, and several other pharmaceutical and medical device manufacturers have introduced this company. Founded in 2014. | Technology Services |
- Borsa valori
- Insiders
- Ryota Nishimori